- Home
- GTY vs XERS Comparison
GTY vs XERS Comparison
Compare GTY & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTY
- XERS
- Stock Information
- Founded
- GTY 1955
- XERS 2005
- Country
- GTY United States
- XERS United States
- Employees
- GTY N/A
- XERS N/A
- Industry
- GTY Real Estate
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- GTY Finance
- XERS Health Care
- Exchange
- GTY Nasdaq
- XERS Nasdaq
- Market Cap
- GTY 1.5B
- XERS 1.3B
- IPO Year
- GTY N/A
- XERS 2018
- Fundamental
- Price
- GTY $27.32
- XERS $7.64
- Analyst Decision
- GTY Buy
- XERS Strong Buy
- Analyst Count
- GTY 5
- XERS 7
- Target Price
- GTY $31.80
- XERS $9.43
- AVG Volume (30 Days)
- GTY 339.1K
- XERS 3.0M
- Earning Date
- GTY 10-22-2025
- XERS 11-06-2025
- Dividend Yield
- GTY 7.10%
- XERS N/A
- EPS Growth
- GTY 10.25
- XERS N/A
- EPS
- GTY 1.28
- XERS N/A
- Revenue
- GTY $214,194,000.00
- XERS $266,137,000.00
- Revenue This Year
- GTY $4.37
- XERS $43.89
- Revenue Next Year
- GTY $12.39
- XERS $20.40
- P/E Ratio
- GTY $21.39
- XERS N/A
- Revenue Growth
- GTY 8.17
- XERS 42.05
- 52 Week Low
- GTY $25.39
- XERS $2.82
- 52 Week High
- GTY $33.85
- XERS $10.08
- Technical
- Relative Strength Index (RSI)
- GTY 48.97
- XERS 36.31
- Support Level
- GTY $26.97
- XERS $7.00
- Resistance Level
- GTY $27.50
- XERS $10.08
- Average True Range (ATR)
- GTY 0.54
- XERS 0.53
- MACD
- GTY -0.04
- XERS -0.26
- Stochastic Oscillator
- GTY 14.86
- XERS 23.38
About GTY Getty Realty Corporation
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).